Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients.
Rahma OE, Ashtar E, Czystowska M, Szajnik ME, Wieckowski E, Bernstein S, Herrin VE, Shams MA, Steinberg SM, Merino M, Gooding W, Visus C, Deleo AB, Wolf JK, Bell JG, Berzofsky JA, Whiteside TL, Khleif SN. Rahma OE, et al. Among authors: wolf jk. Cancer Immunol Immunother. 2012 Mar;61(3):373-84. doi: 10.1007/s00262-011-1100-9. Epub 2011 Sep 17. Cancer Immunol Immunother. 2012. PMID: 21927947 Free PMC article. Clinical Trial.
Religion and sexual identities.
Wolf JK, Platt LF. Wolf JK, et al. Curr Opin Psychol. 2022 Dec;48:101495. doi: 10.1016/j.copsyc.2022.101495. Epub 2022 Oct 26. Curr Opin Psychol. 2022. PMID: 36423507 Review.
Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
Mangala LS, Zuzel V, Schmandt R, Leshane ES, Halder JB, Armaiz-Pena GN, Spannuth WA, Tanaka T, Shahzad MMK, Lin YG, Nick AM, Danes CG, Lee JW, Jennings NB, Vivas-Mejia PE, Wolf JK, Coleman RL, Siddik ZH, Lopez-Berestein G, Lutsenko S, Sood AK. Mangala LS, et al. Among authors: wolf jk. Clin Cancer Res. 2021 Aug 1;27(15):4454. doi: 10.1158/1078-0432.CCR-21-2120. Clin Cancer Res. 2021. PMID: 34341059 No abstract available.
A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment.
Henderson MC, Silver M, Tran Q, Letsios EE, Mulpuri R, Reese DE, Lourenco AP, LaBaer J, Anderson KS, Alpers J, Costantini C, Rohatgi N, Ali H, Baker K, Northfelt DW, Ghosh K, Grobmyer SR, Polen W, Wolf JK. Henderson MC, et al. Among authors: wolf jk. Clin Cancer Res. 2019 Jan 1;25(1):142-149. doi: 10.1158/1078-0432.CCR-18-0843. Epub 2018 Sep 5. Clin Cancer Res. 2019. PMID: 30185421 Clinical Trial.
A Combinatorial Proteomic Biomarker Assay to Detect Ovarian Cancer in Women.
Henderson MC, Silver M, Borman S, Tran Q, Letsios E, Mulpuri R, Reese DE, Wolf JK. Henderson MC, et al. Among authors: wolf jk. Biomark Cancer. 2018 Feb 13;10:1179299X18756646. doi: 10.1177/1179299X18756646. eCollection 2018. Biomark Cancer. 2018. PMID: 35237085 Free PMC article.
97 results